The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a d...
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
About this item
Full title
Author / Creator
Müller, N , Schwarz, M J , Dehning, S , Douhe, A , Cerovecki, A , Goldstein-Müller, B , Spellmann, I , Hetzel, G , Maino, K , Kleindienst, N , Möller, H-J , Arolt, V and Riedel, M
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Signs of an inflammatory process, in particular increased pro-inflammatory cytokines and increased levels of prostaglandine E
2
(PGE
2
), have repeatedly been described in major depression (MD). As cyclooxygenase-2 (COX-2) inhibitors inhibit the PGE
2
production and the production of pro-inflammatory cytokines, we performed a ther...
Alternative Titles
Full title
The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_759317600
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_759317600
Other Identifiers
ISSN
1359-4184
E-ISSN
1476-5578
DOI
10.1038/sj.mp.4001805
